| DBV TECHNOLOGIES EO -,10 |
| Frankreich |
| Gesundheit |
| FR0010417345 / A1JWB7 |
| DBV (Frankfurt) |
| FRA:DBV, ETR:DBV, DBV:GR |
| - |
| https://dbv-technologies... |
|
DBV Technologies SA is a clinical-stage French biopharmaceutical company headquartered in Bagneux, specializing in immunotherapy for food allergies. It pioneers the Viaskin technology, an epicutaneous patch that delivers allergens like peanut or milk..
>Volltext.. |
| 845.2 Mio. EUR |
| 660.2 Mio. EUR |
| - |
| -136.81 Mio. EUR |
| -146.27 Mio. EUR |
| -0.79 EUR |
| 14.32 Mio. EUR |
| 201.32 Mio. EUR |
| -132.23 Mio. EUR |
| 4.42 |
| - |
| -36.63% |
| - |
| - |
| - |
| - |
| DBV TECHNOLOGIES, DBV TECH |
| 14.07.26 |